NEW YORK (GenomeWeb News) – Luminex said after the close of the market Wednesday that it will undertake a restructuring that will result in an undisclosed number of employees being laid off and its Brisbane, Australia office being closed.

The Austin, Texas-based molecular diagnostics developer said that the restructuring will focus on its newborn screening group within its Assay and Related Products segment. In total, the firm expects to reduce its workforce by approximately 5 percent. It currently employs nearly 700 people.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.